Skip to Main Content

ADVERTISEMENT

SCROLL TO CONTINUE WITH CONTENT

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Multiple Sclerosis and Related Disorders

Submit
Log in
Register
Log in
- Submit
- Log in
Subscribe
Claim

Articles
- Latest
- Popular Articles
  
  Review article
  Open Access
  Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases
  Wildner et al.
  Review article
  Open Access
  Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence
  Oreja-Guevara et al.
  Editorial
  Long COVID or post COVID-19 syndrome
  Lechner-Scott et al.
- Latest Articles
  Research Article
  Open Access
  Characteristics and consequences of falls among people with multiple sclerosis who use wheelchairs or scooters: differences between injurious and non-injurious falls
  Zanotto et al.
  Research Article
  Investigation on marital status of patients with neuromyelitis optica spectrum disorders in China
  Mou et al.
  Original article
  Physical function across the lifespan in adults with multiple sclerosis: An application of the Short Physical Performance Battery
  Jeng et al.
Publish
- For Authors
Topics
- - MENACTRIMS Congresses
About
- Journal Information
- Access
  - Subscribe
  - Activate Online Access
Contact
- Contact
- Follow Us
  - New Content Alerts
  - Facebook
    External Link

Advanced search

Advanced search

Please enter a term before submitting your search.

Issue cover

April 2020

Volume 39

Issue cover

Current Issue
Issues in Progress
Articles in Press
Archive
- Articles in Press
- Archive

Select all

Download started.
Ok

Please select at least one article in order to proceed.

Editorial

Big pharma and social responsibility

Big pharma and social responsibility

Christopher H. Hawkes,
Gavin Giovannoni,
Michael Levy,
Jeanette Lechner-Scott,
Emmanuelle Waubant

Published online: March 27, 2020

102069

Full-Text HTML
PDF

Commentary

The COVID-19 pandemic and the use of MS disease-modifying therapies

Gavin Giovannoni,
Chris Hawkes,
Jeannette Lechner-Scott,
Michael Levy,
Emmanuelle Waubant,
Julian Gold

Published online: March 27, 2020

102073

Full-Text HTML
PDF

Review

Neuro-Behcet's disease: An update on diagnosis, differential diagnoses, and treatment

Neuro-Behcet's disease: An update on diagnosis, differential diagnoses, and treatment

Afshin Borhani-Haghighi,
Bahareh Kardeh,
Shubhasree Banerjee,
...
Anahid Safari,
Mohammad Ali Sahraian,
Lee Shapiro

Published online: December 21, 2019

101906

Full-Text HTML
PDF

Patient needs and preferences in relapsing-remitting multiple sclerosis: A systematic review

Patient needs and preferences in relapsing-remitting multiple sclerosis: A systematic review

L.A. Visser,
C. Louapre,
C.A. Uyl-de Groot,
W.K. Redekop

Published online: January 02, 2020

101929

Full-Text HTML
PDF

The role of the clinical nurse specialist multiple sclerosis, the patients’ and families’ and carers’ perspective: An integrative review

The role of the clinical nurse specialist multiple sclerosis, the patients’ and families’ and carers’ perspective: An integrative review

Michelle MEEHAN,
Owen DOODY

Published online: January 05, 2020

101918

Full-Text HTML
PDF
Supplemental Materials

Original Articles

QKI-V5 is downregulated in CNS inflammatory demyelinating diseases

QKI-V5 is downregulated in CNS inflammatory demyelinating diseases

Iris Lavon,
Ina leykin,
Hanna Charbit,
...
Livnat Brill,
Haim Ovadia,
Adi Vaknin-Dembinsky

Published online: December 04, 2019

101881

Full-Text HTML
PDF
Supplemental Materials

Impact of informative censoring on the treatment effect estimate of disability worsening in multiple sclerosis clinical trials

Impact of informative censoring on the treatment effect estimate of disability worsening in multiple sclerosis clinical trials

Katherine Riester,
Ludwig Kappos,
Krzysztof Selmaj,
Stacy Lindborg,
Ilya Lipkovich,
Jacob Elkins

Published online: November 23, 2019

101865

Open Access

Full-Text HTML
PDF
Supplemental Materials

The 5-year Tysabri global observational program in safety (TYGRIS) study confirms the long-term safety profile of natalizumab treatment in multiple sclerosis

John Foley,
Cynthia Carrillo-Infante,
Jonathan Smith,
...
Fabiana Marinelli,
Karen Smirnakis
on behalf of the TYGRIS investigators

Published online: November 21, 2019

101863

Full-Text HTML
PDF
Supplemental Materials

Obesity, dieting, and multiple sclerosis

Obesity, dieting, and multiple sclerosis

R.D. Russell,
A. Langer-Gould,
E.G. Gonzales,
...
R.M. Lucas,
A. Begley,
L.J. Black

Published online: December 09, 2019

101889

Full-Text HTML
PDF

Cross cultural adaptation and psychometric evaluation of an Arabic version of the modified fatigue impact scale in people with multiple sclerosis

Cross cultural adaptation and psychometric evaluation of an Arabic version of the modified fatigue impact scale in people with multiple sclerosis

Hanan Khalil,
Alham Al-Shorman,
Alia A. Alghwiri,
...
Khalid El-Salem,
Sarah Shalabi,
Aseel Aburub

Published online: November 29, 2019

101878

Full-Text HTML
PDF

Factors associated with therapeutic inertia among pharmacists caring for people with multiple sclerosis

Factors associated with therapeutic inertia among pharmacists caring for people with multiple sclerosis

Maria A. Terzaghi,
Cedrik Ruiz,
Iciar Martínez-López,
...
Fabien Bakdache,
Jorge Maurino,
Gustavo Saposnik

Published online: December 09, 2019

101887

Full-Text HTML
PDF

Disease activity impacts disability progression in primary progressive multiple sclerosis

Disease activity impacts disability progression in primary progressive multiple sclerosis

M. Marrodan,
C. Bensi,
A. Pappolla,
...
E. Cristiano,
M.F. Farez,
J. Correale

Published online: December 11, 2019

101892

Full-Text HTML
PDF
Supplemental Materials

Assessing life balance of European people with multiple sclerosis: A multicenter clinimetric study within the RIMS network

Assessing life balance of European people with multiple sclerosis: A multicenter clinimetric study within the RIMS network

Daphne Kos,
Sofie Ferdinand,
Marijke Duportail,
...
Núria Fillo,
Kathleen Matuska,
Heleen Beckerman

Published online: December 04, 2019

101879

Open Access

Full-Text HTML
PDF
Supplemental Materials

No evidence of disease activity status in patients treated with early vs. delayed subcutaneous interferon β-1a

No evidence of disease activity status in patients treated with early vs. delayed subcutaneous interferon β-1a

Mark S. Freedman,
Giancarlo Comi,
Patricia K. Coyle,
...
Liang Chen,
Kurt Marhardt,
Ludwig Kappos

Published online: December 09, 2019

101891

Open Access

Full-Text HTML
PDF
Supplemental Materials

Clinical instrument to retrospectively capture levels of EDSS

Clinical instrument to retrospectively capture levels of EDSS

John Robert Ciotti,
Noah Sanders,
Amber Salter,
Joseph R. Berger,
Anne Haney Cross,
Salim Chahin

Published online: December 03, 2019

101884

Full-Text HTML
PDF
Supplemental Materials

Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumab

Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumab

Tjalf Ziemssen,
Michael Lang,
Björn Tackenberg,
...
Christian Cornelissen,
Benjamin Ettle
on behalf of the PANGAEA Study Group

Published online: December 11, 2019

101893

Open Access

Full-Text HTML
PDF

NLRP3 level in cerebrospinal fluid of patients with neuromyelitis optica spectrum disorders: Increased levels and association with disease severity

NLRP3 level in cerebrospinal fluid of patients with neuromyelitis optica spectrum disorders: Increased levels and association with disease severity

Yu Peng,
Jinyu Chen,
Yongqiang Dai,
...
Wei Qiu,
Yong Gu,
Honghao Wang

Published online: December 07, 2019

101888

Full-Text HTML
PDF

Prevalence of self-reported language impairment in multiple sclerosis and the association with health-related quality of life: An international survey study

Sarah El-Wahsh,
Kirrie Ballard,
Fiona Kumfor,
Hans Bogaardt

Published online: December 17, 2019

101896

Full-Text HTML
PDF

The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis

Lorena Lorefice,
Francesco Destro,
Giuseppe Fenu,
...
Maria Giovanna Marrosu,
Luca Saba,
Eleonora Cocco

Published online: December 09, 2019

101886

Full-Text HTML
PDF

Thalamo-cortical dysfunction contributes to fatigability in multiple sclerosis patients: A neurophysiological study

Thalamo-cortical dysfunction contributes to fatigability in multiple sclerosis patients: A neurophysiological study

Fioravante Capone,
Francesco Motolese,
Mariagrazia Rossi,
Gabriella Musumeci,
Angelo Insola,
Vincenzo Di Lazzaro

Published online: December 17, 2019

101897

Full-Text HTML
PDF

Identification of Multiple Sclerosis key genetic factors through multi-staged data mining

Identification of Multiple Sclerosis key genetic factors through multi-staged data mining

Mohammad Navaderi,
Saeideh Rajaei,
Samira Rahimirad,
...
Zahra Behgar,
Alireza Mirzaee Sedigh,
Mohammad Hossein Sanati

Published online: October 22, 2019

101446

Full-Text HTML
PDF
Supplemental Materials

Validation of 0–10 MS symptom scores in the Australian multiple sclerosis longitudinal study

Validation of 0–10 MS symptom scores in the Australian multiple sclerosis longitudinal study

Yan Zhang,
Bruce V Taylor,
Steve Simpson Jr.,
Leigh Blizzard,
Andrew J Palmer,
Ingrid van der Mei

Published online: December 17, 2019

101895

Full-Text HTML
PDF
Supplemental Materials

Impairments of humour comprehension in multiple sclerosis

Impairments of humour comprehension in multiple sclerosis

Nathalie Ehrlé,
Pauline Espi,
Jennifer Labire,
Alice Loizeau,
Camille Menard,
Serge Bakchine

Published online: October 14, 2019

101443

Full-Text HTML
PDF

Effectiveness of glatiramer acetate in neutralizing antibody-positive patients previously treated with interferon-β

Effectiveness of glatiramer acetate in neutralizing antibody-positive patients previously treated with interferon-β

Mathias Due Buron,
Melinda Magyari,
Thor Ameri Chalmer,
Per Soelberg Sørensen,
Finn Sellebjerg

Published online: December 17, 2019

101894

Full-Text HTML
PDF
Supplemental Materials

Low CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosis

Low CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosis

Anna M. Pietroboni,
Annalisa Colombi,
Tiziana Carandini,
...
Fabio Triulzi,
Elio Scarpini,
Daniela Galimberti

Published online: December 19, 2019

101899

Full-Text HTML
PDF

Photoreceptor outer nuclear layer thickness changes in optic neuritis follow up

Photoreceptor outer nuclear layer thickness changes in optic neuritis follow up

Masoud Aghsaei Fard,
Alireza Golizadeh,
Samira Yadegari,
Hossein Ghahvehchian,
Prem Subramanian,
Robert Ritch

Published online: December 20, 2019

101905

Full-Text HTML
PDF

To treat or not to treat: Sequential individualized treatment evaluation in relapsing multiple sclerosis

To treat or not to treat: Sequential individualized treatment evaluation in relapsing multiple sclerosis

Gabriel Bsteh,
Harald Hegen,
Carolin Dosser,
...
Franziska Di Pauli,
Florian Deisenhammer,
Thomas Berger

Published online: December 23, 2019

101908

Full-Text HTML
PDF

Pediatric optic neuritis and anti MOG antibodies: a cohort of Italian patients

Pediatric optic neuritis and anti MOG antibodies: a cohort of Italian patients

Thea Giacomini,
Thomas Foiadelli,
Pietro Annovazzi,
...
Stefano Sartori,
Salvatore Savasta,
Maria Margherita Mancardi

Published online: December 24, 2019

101917

Full-Text HTML
PDF

Relative importance of vision and proprioception in maintaining standing balance in people with multiple sclerosis

Relative importance of vision and proprioception in maintaining standing balance in people with multiple sclerosis

Feng Yang,
Xinyue Liu

Published online: December 20, 2019

101901

Full-Text HTML
PDF

Correlations of health status indicators with perceived neuropsychological impairment and cognitive processing speed in multiple sclerosis

Correlations of health status indicators with perceived neuropsychological impairment and cognitive processing speed in multiple sclerosis

Marie B. D'hooghe,
Alexander De Cock,
Ann Van Remoortel,
...
Miguel D'haeseleer,
Jacques De Keyser,
Guy Nagels

Published online: December 20, 2019

101904

Full-Text HTML
PDF

Effectiveness of subcutaneous tocilizumab in neuromyelitis optica spectrum disorders

Effectiveness of subcutaneous tocilizumab in neuromyelitis optica spectrum disorders

Itay Lotan,
Robert W. Charlson,
Lana Zhovtis Ryerson,
Michael Levy,
Ilya Kister

Published online: December 30, 2019

101920

Full-Text HTML
PDF

Comparison of the effects of two different exergaming systems on balance, functionality, fatigue, and quality of life in people with multiple sclerosis: A randomized controlled trial

Comparison of the effects of two different exergaming systems on balance, functionality, fatigue, and quality of life in people with multiple sclerosis: A randomized controlled trial

Yonca Zenginler Yazgan,
Ela Tarakci,
Devrim Tarakci,
Arzu Razak Ozdincler,
Murat Kurtuncu

Published online: December 20, 2019

101902

Full-Text HTML
PDF

Amyloid PET findings in multiple sclerosis are associated with cognitive decline at 18 months

Amyloid PET findings in multiple sclerosis are associated with cognitive decline at 18 months

Vanesa Pytel,
Jordi A. Matias-Guiu,
Jorge Matías-Guiu,
...
Juan Arrazola,
José Luis Carreras,
María Nieves Cabrera-Martín

Published online: January 02, 2020

101926

Full-Text HTML
PDF
Supplemental Materials

Do clinical trials for new disease modifying treatments include real world patients with multiple sclerosis?

Do clinical trials for new disease modifying treatments include real world patients with multiple sclerosis?

Juan Ignacio Rojas,
Agustín Pappolla,
Liliana Patrucco,
Edgardo Cristiano,
Francisco Sánchez

Published online: January 05, 2020

101931

Full-Text HTML
PDF

Do Secondary Progressive Multiple Sclerosis patients benefit from Computer- based cognitive neurorehabilitation? A randomized sham controlled trial

Do Secondary Progressive Multiple Sclerosis patients benefit from Computer- based cognitive neurorehabilitation? A randomized sham controlled trial

Lambros Messinis,
Mary H Kosmidis,
Grigorios Nasios,
...
Philippos Gourzis,
Sonia Malefaki,
Panagiotis Papathanasopoulos

Published online: January 06, 2020

101932

Full-Text HTML
PDF

Objective sensor-based gait measures reflect motor impairment in multiple sclerosis patients: Reliability and clinical validation of a wearable sensor device

Objective sensor-based gait measures reflect motor impairment in multiple sclerosis patients: Reliability and clinical validation of a wearable sensor device

Felix Flachenecker,
Heiko Gaßner,
Julius Hannik,
...
Bjoern Eskofier,
Ralf A. Linker,
Jochen Klucken

Published online: December 21, 2019

101903

Full-Text HTML
PDF
Supplemental Materials

Tacrolimus is effective for neuromyelitis optica spectrum disorders with or without anti-AQP4 antibody

Tacrolimus is effective for neuromyelitis optica spectrum disorders with or without anti-AQP4 antibody

Miki Kojima,
Satoru Oji,
Satoru Tanaka,
...
Baku Hashimoto,
Hikoaki Fukaura,
Kyoichi Nomura

Published online: December 26, 2019

101907

Full-Text HTML
PDF

Case Reports

Cerebral toxoplasmosis in patient with relapsing-remitting multiple sclerosis under treatment with alemtuzumab

Cerebral toxoplasmosis in patient with relapsing-remitting multiple sclerosis under treatment with alemtuzumab

Calle-Calle Raquel,
Triguero-Cueva Lucía,
Valderrama-Martín Carmen,
...
Tapia-Gómez Antonio,
Pasquau-Liaño Juan,
Arnal-García Carmen

Published online: December 04, 2019

101885

Full-Text HTML
PDF

Neurofibromatosis type 2 and multiple sclerosis

Neurofibromatosis type 2 and multiple sclerosis

Dario-Lucas Helbing,
Michael Brodhun,
Oliver Tiedge,
Helen Morrison,
Steffen K. Rosahl

Published online: December 09, 2019

101890

Full-Text HTML
PDF

Tumefactive rebound of multiple sclerosis after the short-term cessation of fingolimod: A case report

Tumefactive rebound of multiple sclerosis after the short-term cessation of fingolimod: A case report

Fereshteh Ashtari,
Mohammad Ali Sahraian,
Marjan Oustad,
Yalda nilipour

Published online: December 06, 2019

101883

Full-Text HTML
PDF

A case of GFAP-astroglial autoimmunity presenting with reversible parkinsonism

A case of GFAP-astroglial autoimmunity presenting with reversible parkinsonism

Anna Tomczak,
Elaine Su,
Madina Tugizova,
...
Lucas B. Kipp,
Haojun Feng,
May H. Han

Published online: December 19, 2019

101900

Full-Text HTML
PDF

Cryptococcus neoformans var grubii meningoencephalitis in a patient on fingolimod for relapsing-remitting multiple sclerosis: Case report and review of published cases

SB Ma,
DWJ Griffin,
SC Boyd,
CC Chang,
JSJ Wong,
SD Guy

Published online: January 05, 2020

101923

Full-Text HTML
PDF

$Autoimmune glial fibrillary acidic protein astrocytopathy resulting in treatment-refractory flaccid paralysis$

Autoimmune glial fibrillary acidic protein astrocytopathy resulting in treatment-refractory flaccid paralysis

Alexander Allen,
Shivam Gulhar,
Ramin Haidari,
...
Robert DeLorenzo,
Yang Tang,
Unsong Oh

Published online: January 05, 2020

101924

Full-Text HTML
PDF

Login to your account

Email/Username

Password

Forgot password?

Remember me

Don’t have an account?

Create a Free Account

If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

Email*

If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.

Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.

Privacy Policy
Terms and Conditions
Accessibility
Help & Contact

RELX